No Data
No Data
Express News | Cosmos Health's Subsidiary Cana Laboratories Completes Phase I Of Manufacturing Upgrades; Positioned To Generate Over $10M In Recurring Annual Gross Profit By End Of 2025
Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity
Scorum Powers Aviatrix's Exclusive Web3 Debut on Cosmos
Cosmos Machinery Secures Discounted Property Deal
Cosmos Health Regains Nasdaq Compliance
Cosmos Health Regains Compliance With Nasdaq Minimum Bid Price Rule
No Data